Next-gen Novo Nordisk shot shows 22% weight loss in early results
One of Novo Nordisk's next-generation obesity shots to follow up on its success with Wegovy helped patients lose 22% of their weight in 36 weeks, according to early-stage trial results on Friday, boosting the drugmaker's shares.
Novo Nordisk stock pops on Phase 1 data for new weight loss drug amycretin
Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 products, by mimicking a hormone in the body that provides a satiated feeling and curbs hunger, but adds a different hormone in the pancreas.
What’s behind the meteoric rise of weight-loss drugs in Massachusetts?
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims data.
Novo Nordisk reports 22% weight loss in early subcutaneous amycretin trial
Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying people with obesity or overweight treated with the drug achieved a 22% weight loss after 36 weeks.
Weight-Loss Drugs Like Ozempic Linked To Lower Risk Of 42 Conditions
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.
Novo Shares Soar as Experimental Shot Shows 22% Weight Loss
Novo Nordisk A/S rose the most since August 2023 after its experimental shot delivered as much as 22% weight loss in an early-stage trial, boosting investors’ hopes for the drugmaker’s pipeline.
Novo Nordisk Stock Soars on New Weight-Loss Drug Results
Novo Nordisk scored a much-needed win on Friday, with early-stage data on a new weight-loss drug that suggested it could work better than the obesity blockbusters already on the market. Novo American depositary receipt was down 38% in the six months prior to Friday’s announcement,
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.
Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results
Novo Nordisk reported strong early-stage results for its once-a-week obesity drug. Early Friday, Novo Nordisk stock jumped. Eli Lilly fell.
How Much Weight Can I Safely Lose in Just a Week?
Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...
Gemma Collins shows off glamorous new look after dramatic weight loss
Gemma Collins opened up about her weight loss as she showed off her glamorous new make-up look on social media ...
Carbonated Water Could Boost Weight Loss, New Study Suggests: Here's What To Know, According To A Dietitian
Don't expect to shed pounds solely due to your choice of beverage. The benefits of drinking carbonated water for weight loss ...
Carbonated Water 'May Promote Weight Loss,' According to New Study
The body absorbs the carbon in a way that “may support weight loss,” according to a new study, but carbonated drinks are not ...
What you should know about carbonated water and weight loss
Carbonated drinks known as sparkling, fizzy, seltzer and soda waters are thought to impact the waistline. A new study weighs in, but don’t expect too much.
The Express Tribune3h
Gemma Collins reveals weight loss transformation using Mounjaro injections
Gemma Collins reveals weight loss with Mounjaro injections, showcasing a new look and expressing newfound confidence.
Novo Nordisk next-gen shot shows 22% weight loss in early results
One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...
Does fizzy water help you lose weight? Here’s what the research says
A study published in BMJ Nutrition, Prevention & Health suggests the CO2 in carbonated water might help with weight loss by boosting how red blood cells process glucose.